We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HIG:NYSEThe Hartford Insurance Group, Inc. Analysis

Data as of 2026-05-21 - not real-time

$136.69

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The Hartford (HIG) is trading at $136.69, comfortably above its 20‑day ($134.96), 50‑day ($135.61) and 200‑day ($133.99) moving averages, indicating short‑term momentum support. The stock’s RSI of 54 and a bullish MACD histogram (+0.32) suggest neutral to mildly positive technical bias, while volatility over the past 30 days sits near 20%, higher than typical for the insurance sector. Fundamentally, HIG trades at a trailing P/E of 9.6 versus an industry average of 16.7, positioning it as a clear value play, and its forward P/E of 9.5 reinforces this discount. The company posted 6.1% revenue growth YoY, a solid profit margin of 14.1% and an impressive ROE of 22.7%, underscoring strong profitability. Cash flow remains robust with $5.98 B operating cash flow and a low payout ratio of 15.8%, supporting the 1.76% dividend yield and suggesting dividend sustainability. However, Q1 2026 non‑GAAP earnings of $3.09 per share missed consensus by 8.8%, introducing a near‑term earnings‑miss risk. Analyst consensus remains bullish (Buy) with a median price target of $149, implying roughly 9% upside, and the Fear & Greed Index’s “Extreme Greed” stance reflects heightened market optimism.
Given a low beta of 0.27, modest debt levels and a stable liquidity profile, HIG presents a defensively positioned investment with attractive valuation metrics. The modest upside, strong cash generation, and sustainable dividend make it a compelling addition for medium‑ to long‑term portfolios, while the recent earnings miss tempers short‑term expectations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Q1 earnings miss versus consensus
  • Technical price near support at $131.08
  • Stable dividend yield of 1.76%

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued P/E relative to industry
  • Strong ROE and revenue growth
  • Attractive upside to analyst target price

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Durable insurance franchise with low beta
  • Consistent cash flow supporting dividend sustainability
  • Long‑term value upside and defensive sector positioning

Key Metrics & Analysis

Financial Health

Revenue Growth6.10%
Profit Margin14.11%
P/E Ratio9.6
ROE22.74%
ROA3.88%
Debt/Equity23.15
P/B Ratio2.0
Op. Cash Flow$6.0B
Free Cash Flow$5.6B
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI54.1
Support$131.08
Resistance$140.11
MA 20$134.96
MA 50$135.61
MA 200$133.99
MACDBullish
VolumeStable
Fear & Greed Index90.55

Valuation

Fair Value$340.36
Target Price$149.45
Upside/Downside9.33%
GradeUndervalued
TypeBlend
Dividend Yield1.76%

Risk Assessment

Beta0.27
Volatility19.97%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.